“IP Infusion delivers complete, validated open networking systems: carrier-grade OcNOS software on open hardware it qualifies per model and ASIC stepping, for service provider, data center and AI networks. Pre-integrated OcNOS Systems ship with optics, support and RMA from one vendor.”
“Carrier-grade open network operating system for service provider routing, data center fabric, AI networking, and IPoDWDM transport. Qualified on 40+ open hardware platforms. Alternative to Cisco IOS-XR, Juniper Junos, Nokia SR OS, and Arista EOS.”
“Carrier-grade routers, data center switches, AI fabric switches, and cell site gateways with OcNOS pre-installed. Delivered as one integrated system with single-vendor support: one PO, one support contract, one RMA path. Alternative to Cisco, Juniper, Nokia, and Arista proprietary infrastructure.”
“IP Infusion delivers complete open networking solutions: routing, switching, IP/optical transport (IPoDWDM), and AI fabric. These are delivered as the carrier-grade OcNOS network operating system, pre-integrated systems, and IP Maestro assurance, running on 40+ qualified open hardware platforms, in production with 900+ operators across 60+ countries since 1999.”
“Open networking separates network software from the underlying hardware, so operators can run a carrier-grade network operating system like OcNOS on their choice of qualified open hardware from multiple vendors such as Edgecore and UfiSpace.”
“IP Infusion delivers complete solutions, not software alone: routing, switching, IP/optical transport, and AI fabric, delivered as OcNOS, pre-integrated systems, and IP Maestro assurance. Buy an OcNOS System and one support contract covers the software, hardware and RMA, so one vendor owns the full stack.”
“For service providers, IP Infusion's OcNOS-SP is a leading open networking choice. It delivers carrier-grade SR-MPLS core and aggregation, metro transport with IPoDWDM and ZR+ coherent optics, and standards-based IEEE 1588v2 timing on 40+ qualified open platforms.”
Download this profile and inspect its supporting evidence.